Andrographolide Induces Noxa-Dependent Apoptosis by Transactivating ATF4 in Human Lung Adenocarcinoma Cells
Junqian Zhang1, Chunjie Li1, Li Zhang1
1Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Abstract:
Lung adenocarcinoma is the most common pathological type of lung cancer with poor patient outcomes; therefore, developing novel therapeutic agents is critically needed. Andrographolide (AD), a major active component derived from the traditional Chinese medicine (TCM) Andrographis paniculate, is a potential antitumor drug, but the role of AD in lung adenocarcinoma remains poorly understood. In the present study, we demonstrated that AD inhibited the proliferation of broad-spectrum lung cancer cell lines in a dose-dependent manner. Meanwhile, we found that a high dose of AD induced Noxa-dependent apoptosis in human lung adenocarcinoma cells (A549 and H1299). Further studies revealed that Noxa was transcriptionally activated by activating transcription factor 4 (ATF4) in AD-induced apoptosis. Knockdown of ATF4 by small interfering RNA (siRNA) significantly diminished the transactivation of Noxa as well as the apoptotic population induced by AD. These results of the present study indicated that AD induced apoptosis of human lung adenocarcinoma cells by activating the ATF4/Noxa axis and supporting the development of AD as a promising candidate for the new era of chemotherapy.
Insights
Andrographolide (AD) inhibits lung adenocarcinoma cell growth. This traditional Chinese medicine component induces apoptosis by activating the ATF4/Noxa pathway, offering a promising new chemotherapy candidate.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Lung adenocarcinoma presents poor patient outcomes, necessitating novel therapeutic strategies.
- Andrographolide (AD), from traditional Chinese medicine, shows potential antitumor activity but its role in lung adenocarcinoma is unclear.
Purpose of the Study:
- To investigate the therapeutic potential and underlying mechanism of Andrographolide (AD) in lung adenocarcinoma.
Main Methods:
- Assessed AD's effect on lung cancer cell proliferation.
- Investigated AD-induced apoptosis and the role of Noxa and ATF4 using cell lines (A549, H1299) and siRNA knockdown.
Main Results:
- AD inhibited lung cancer cell proliferation dose-dependently.
- High-dose AD induced Noxa-dependent apoptosis, mediated by ATF4 transcriptional activation of Noxa.
- ATF4 knockdown reduced Noxa transactivation and AD-induced apoptosis.
Conclusions:
- AD induces apoptosis in human lung adenocarcinoma cells via the ATF4/Noxa axis.
- AD demonstrates potential as a novel chemotherapeutic agent for lung adenocarcinoma.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
13:53Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-Treated SiHa Cervical Cancer Cells
Published on: August 26, 2021
Related Concept Videos
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis
The Extrinsic Apoptotic Pathway
